X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12860) 12860
Book Review (3120) 3120
Publication (890) 890
Newsletter (357) 357
Newspaper Article (128) 128
Book Chapter (122) 122
Conference Proceeding (34) 34
Magazine Article (14) 14
Book / eBook (13) 13
Dissertation (10) 10
Reference (9) 9
Trade Publication Article (4) 4
Data Set (2) 2
Transcript (2) 2
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (11208) 11208
humans (8614) 8614
male (5986) 5986
glucose (5468) 5468
female (5251) 5251
diabetes (4413) 4413
animals (3998) 3998
insulin resistance (3992) 3992
endocrinology & metabolism (3936) 3936
middle aged (3354) 3354
insulin (3308) 3308
adult (3146) 3146
blood glucose - metabolism (2845) 2845
type 2 diabetes (2540) 2540
obesity (2516) 2516
dextrose (2437) 2437
insulin-resistance (2137) 2137
risk factors (2110) 2110
aged (1951) 1951
mice (1929) 1929
glucose tolerance test (1901) 1901
glucose metabolism (1862) 1862
insulin - blood (1824) 1824
diabetes mellitus (1757) 1757
hypoglycemic agents - therapeutic use (1726) 1726
diabetes mellitus, type 2 - drug therapy (1661) 1661
metabolism (1646) 1646
rats (1591) 1591
research (1588) 1588
physiological aspects (1583) 1583
hyperglycemia (1478) 1478
abridged index medicus (1422) 1422
analysis (1331) 1331
metabolic syndrome (1324) 1324
blood glucose - analysis (1274) 1274
glucose - metabolism (1268) 1268
health aspects (1268) 1268
insulin - metabolism (1266) 1266
pharmacology & pharmacy (1164) 1164
care and treatment (1095) 1095
rodents (1074) 1074
mellitus (1059) 1059
diabetes mellitus, type 2 - blood (1028) 1028
medicine & public health (1009) 1009
hypertension (998) 998
blood glucose - drug effects (989) 989
diet (942) 942
body mass index (905) 905
internal medicine (897) 897
risk (879) 879
diabetes mellitus, type 2 - metabolism (871) 871
oxidative stress (867) 867
prevalence (854) 854
diabetes therapy (829) 829
treatment outcome (823) 823
impaired glucose-tolerance (819) 819
diabetes-mellitus (812) 812
pregnancy (808) 808
glucose tolerance (807) 807
homeostasis (802) 802
adolescent (795) 795
inflammation (793) 793
mice, inbred c57bl (792) 792
drug therapy (774) 774
nutrition & dietetics (770) 770
medicine (761) 761
body weight (760) 760
medicine, general & internal (737) 737
insulin secretion (736) 736
physiology (724) 724
insulin resistance - physiology (718) 718
research article (718) 718
insulin sensitivity (717) 717
metformin (716) 716
liver (714) 714
hypoglycemic agents - pharmacology (712) 712
resistance (704) 704
cholesterol (690) 690
prevention (678) 678
lipids (677) 677
mortality (677) 677
glucose intolerance - drug therapy (676) 676
glucose-tolerance (671) 671
insulin - therapeutic use (670) 670
liver - metabolism (668) 668
cardiovascular-disease (656) 656
diabetes mellitus, type 2 - complications (656) 656
article (655) 655
biochemistry & molecular biology (655) 655
blood sugar (642) 642
fasting (642) 642
time factors (640) 640
obesity - metabolism (636) 636
glycemic control (635) 635
triglycerides - blood (635) 635
lipids - blood (628) 628
studies (625) 625
secretion (622) 622
disease (612) 612
type-2 diabetes-mellitus (609) 609
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13333) 13333
Japanese (41) 41
German (22) 22
French (14) 14
Russian (13) 13
Spanish (12) 12
Chinese (10) 10
Italian (7) 7
Polish (7) 7
Portuguese (6) 6
Hungarian (3) 3
Turkish (3) 3
Czech (2) 2
Romanian (2) 2
Danish (1) 1
Serbian (1) 1
Swedish (1) 1
Ukrainian (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Gerstein, Hertzel C and Bosch, Jackie and Dagenais, Gilles R and Díaz, Rafael and Jung, Hyejung and Maggioni, Aldo P and Pogue, Janice and Probstfield, Jeffrey and Ramachandran, Ambady and Riddle, Matthew C and Rydén, Lars E and Yusuf, Salim and Richardson, L and Diaz, R and Johnston, P and Vige, R and Birkeland, K and Budaj, A and Cardona, E and Chazova, I and Commerford, P and Danilova, L and Davies, M and Fernando, R and Fodor, G and Gilbert, R and Gomis, R and Hâncu, N and Hanefeld, M and Hildebrandt, P and Kacerovsky-Bielesz, G and Keltai, M and Kim, J.H and Krum, H and Kültürsay, H and Lanas, F and Lewis, B.S and Lonn, E and López-Jaramillo, P and Marin-Neto, J and Marre, M and McKelvie, R and McQueen, M and Mendoza, I and Morillo, C and Pan, C and Pīrāgs, V and Profozic, V and Ratner, R and Richardson, L and Rosenstock, J and Spinas, G.A and Sreenan, S and Stoel, I and Syvänne, M and Yale, J.F and Avezum, A and Bahit, M.C and Bogaty, P and Bordeleau, L and Chacόn, C and Corson, M and Harper, W.L and Halon, D and Magloire, P and Mann, J and Pavlova, V and Punthakee, Z and Silva, J and Tsang, B and Yakubovich, N and Abdallah, A and Ahmad, S and Chandra, J and Chandra, R and Cukierman-Yaffee, T and Dyal, L and Joldersma, L and MacRae, L and MacRae, S and Malik, S and Mead, A and Pasha, F and Pazmino-Canizares, J and Pohl, K and Sakalas, A and Tyrwhitt, J and Ahuad Guerrero, R and Alebuena, A and Alvarez, N and Alzogaray, M and Amuchastegui, M and Andres, M and Angos, M and Baglivo, H and Barbieri, M and Bassi, F and Bello, F and Bono, J and Bustamante Labarta, M and ... and The ORIGIN Trial Investigators and ORIGIN Trial Investigators and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Centrum för klinisk forskning, Västerås
The New England Journal of Medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 4, pp. 319 - 328
In this study with a 2-by-2 factorial design, patients with cardiovascular risk factors and dysglycemia or type 2 diabetes received insulin glargine or... 
DIABETES-MELLITUS | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | THERAPY | GLARGINE | GLUCOSE CONTROL | DISEASE | RISK | PEOPLE | ENDOTHELIAL FUNCTION | BETA-CELL FUNCTION | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Cardiovascular Diseases - epidemiology | Female | Drug Therapy, Combination | Hypoglycemia - chemically induced | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Fasting | Blood Glucose - analysis | Double-Blind Method | Proportional Hazards Models | Hospitalization | Glucose Intolerance - complications | Insulin, Long-Acting - adverse effects | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Care and treatment | Insulin glargine | Patient outcomes | Causes of | Cardiovascular diseases | Risk factors | Myocardial infarction | Fees & charges | Cerebral infarction | Medical research | Stroke | Heart attacks | Statistical analysis | Diabetes mellitus | Glucose | Hypoglycemia | Fatty acids | Insulin | Glucose tolerance | Insulin resistance | Microvasculature | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Index Medicus | Abridged Index Medicus | Cardiovascular Diseases | Insulin, Long-Acting | Blood Glucose | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3 | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2010, Volume 362, Issue 16, pp. 1477 - 1490
In this large clinical trial, the angiotensin-receptor blocker valsartan reduced the risk of diabetes in patients with impaired glucose tolerance. However, the... 
FASTING GLUCOSE | TRIAL | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | LIFE-STYLE INTERVENTIONS | DISEASE | PREVENTION | COMPONENTS | IMPAIRED GLUCOSE-TOLERANCE | MELLITUS | CONVERTING-ENZYME-INHIBITORS | Angiotensin II Type 1 Receptor Blockers - adverse effects | Follow-Up Studies | Phenylalanine - analogs & derivatives | Valsartan | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Body Weight - drug effects | Male | Diabetes Mellitus, Type 2 - epidemiology | Incidence | Cyclohexanes - therapeutic use | Glucose Intolerance - drug therapy | Exercise | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Blood Pressure - drug effects | Phenylalanine - therapeutic use | Drug Therapy, Combination | Hypoglycemic Agents - therapeutic use | Blood Glucose - analysis | Double-Blind Method | Risk Factors | Valine - analogs & derivatives | Diabetes Mellitus, Type 2 - prevention & control | Proportional Hazards Models | Blood Glucose - drug effects | Glucose Intolerance - diet therapy | Tetrazoles - therapeutic use | Valine - therapeutic use | Tetrazoles - adverse effects | Valine - adverse effects | Glucose Intolerance - therapy | Evaluation | Care and treatment | Glucose intolerance | Diabetes | Cardiovascular diseases | Drug therapy | Cardiovascular disease | Index Medicus | Abridged Index Medicus | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 06/2012, Volume 97, Issue 6, pp. 2039 - 2049
Journal Article
Journal Article